Independent drug action in combination therapy: implications for precision oncology

D Plana, AC Palmer, PK Sorger - Cancer discovery, 2022‏ - AACR
Combination therapies are superior to monotherapy for many cancers. This advantage was
historically ascribed to the ability of combinations to address tumor heterogeneity, but …

Drug combinations: a strategy to extend the life of antibiotics in the 21st century

M Tyers, GD Wright - Nature Reviews Microbiology, 2019‏ - nature.com
Antimicrobial resistance threatens a resurgence of life-threatening bacterial infections and
the potential demise of many aspects of modern medicine. Despite intensive drug discovery …

Network-based prediction of drug combinations

F Cheng, IA Kovács, AL Barabási - Nature communications, 2019‏ - nature.com
Drug combinations, offering increased therapeutic efficacy and reduced toxicity, play an
important role in treating multiple complex diseases. Yet, our ability to identify and validate …

Modeling polypharmacy side effects with graph convolutional networks

M Zitnik, M Agrawal, J Leskovec - Bioinformatics, 2018‏ - academic.oup.com
Motivation The use of drug combinations, termed polypharmacy, is common to treat patients
with complex diseases or co-existing conditions. However, a major consequence of …

[HTML][HTML] Next-generation machine learning for biological networks

DM Camacho, KM Collins, RK Powers, JC Costello… - Cell, 2018‏ - cell.com
Machine learning, a collection of data-analytical techniques aimed at building predictive
models from multi-dimensional datasets, is becoming integral to modern biological research …

Machine learning for integrating data in biology and medicine: Principles, practice, and opportunities

M Zitnik, F Nguyen, B Wang, J Leskovec… - Information …, 2019‏ - Elsevier
New technologies have enabled the investigation of biology and human health at an
unprecedented scale and in multiple dimensions. These dimensions include a myriad of …

DeepSynergy: predicting anti-cancer drug synergy with Deep Learning

K Preuer, RPI Lewis, S Hochreiter, A Bender… - …, 2018‏ - academic.oup.com
Motivation While drug combination therapies are a well-established concept in cancer
treatment, identifying novel synergistic combinations is challenging due to the size of …

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

MP Menden, D Wang, MJ Mason, B Szalai… - Nature …, 2019‏ - nature.com
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

N Fujiwara, N Kubota, E Crouchet, B Koneru… - Science translational …, 2022‏ - science.org
Prediction of hepatocellular carcinoma (HCC) risk is an urgent unmet need in patients with
nonalcoholic fatty liver disease (NAFLD). In cohorts of 409 patients with NAFLD from …

Toward understanding and exploiting tumor heterogeneity

AA Alizadeh, V Aranda, A Bardelli, C Blanpain… - Nature medicine, 2015‏ - nature.com
The extent of tumor heterogeneity is an emerging theme that researchers are only beginning
to understand. How genetic and epigenetic heterogeneity affects tumor evolution and …